- Home
- PYXS vs NNOX Comparison
PYXS vs NNOX Comparison
Compare PYXS & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PYXS | NNOX |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 253.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PYXS | NNOX |
|---|---|---|
| Price | $1.64 | $3.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $6.75 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 11-03-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,820,000.00 | ★ $12,302,000.00 |
| Revenue This Year | N/A | $20.19 |
| Revenue Next Year | N/A | $137.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.19 |
| 52 Week Low | $0.83 | $2.76 |
| 52 Week High | $5.55 | $9.11 |
Technical Indicators
Market Signals| Indicator | PYXS | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 39.72 | 58.92 |
| Support Level | $1.60 | $2.90 |
| Resistance Level | $1.76 | $3.20 |
| Average True Range (ATR) | 0.20 | 0.16 |
| MACD | 0.11 | 0.05 |
| Stochastic Oscillator | 48.78 | 96.59 |
Price Performance
Historical ComparisonAbout PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.